Brain GLP-1 and insulin sensitivity
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 418, 27-32
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone ActionCell Metabolism, 2013
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studyThe Lancet, 2013
- The Anorectic Effect of GLP-1 in Rats Is Nutrient DependentPLOS ONE, 2012
- Wired on sugar: the role of the CNS in the regulation of glucose homeostasisNature Reviews Neuroscience, 2012
- Investigation of the haemodynamic effects of exenatide in healthy male subjectsBritish Journal of Clinical Pharmacology, 2012
- Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesisBMC Neuroscience, 2012
- Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in miceJournal of Clinical Investigation, 2012
- Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2011
- Hypothalamic control of energy and glucose metabolismReviews in Endocrine and Metabolic Disorders, 2011